OVERVIEW

Brain health is recognized as an essential part of successful aging. To promote longevity and quality of life, optimal brain functioning across cognitive, social, emotional, and behavioral domains allows a person to realize their full potential over their lifetime. Anxiety, depression and other mental health condition in later life can reduce longevity, increase the risk of medical and cognitive disorders and lead to poorer outcomes. Most concerning is the fact that the prevalence of cognitive disorders is increasing rapidly as people live longer. Reducing the risk of cognitive disorders such as Alzheimer’s Disease and Related Dementias (ADRD) is as essential to the clinician as reducing hypertension and diabetes in reducing cardiovascular disease. 

This seminar is designed to educate the practitioners and equip them with essential knowledge and state-of-the-art scientific methods to diagnose Alzheimer’s Disease and Related Dementias (ADRD) at its earliest stages and assist patients and their loved ones. Understanding normal cognitive aging and stradegies to reduce the risk of developing Alzheimer’s disease will also be discussed. Drawing on the presenters’ vast scientific and clinical expertise, the participants will be able to differentiate different cognitive syndromes and the etiological underpinnings of various clinical presentations. In addition, the participant will be familiarized with state-of-the-art neuropsychological and novel neuroimaging and plasma-based biomarkers methods to detect the earliest stages of Alzheimer’s Disease.  

This presentation will also provide a comprehensive review of essential geriatric psychopharmacology in the treatment of the most common psychiatric and mental health conditions as well as the latest in emerging pharmacological agents in the treatment and management of Alzheimer’s Disease and its comorbid psychiatric and behavioral manifestations.  

TARGET AUDIENCE

Health professionals in psychiatry, psychology, neurology, medicine, surgery, geriatrics, pediatrics, nursing, social work, and counseling

LEARNING OBJECTIVES

• Differentiate between normal cognitive aging, mild cognitive impairment (MCI), and clinical dementia;
  
• Discuss how to identify the underlying brain disorders causing clinical cognitive impairment in older adults;
• Identify the evidence-based, emerging brain biomarkers in cognitive disorders that help to diagnose at-risk older individuals for Alzheimer’s Disease and Related Dementias (ADRD);
• Identify the role of traditional and novel cognitive neuropsychological testing in early diagnosis of cognitive disorders in older individuals; 
• Differentiate Alzheimer’s Disease from non- Alzheimer’s Disease pathology; 
• Describe current pharmacological and nonpharmacological approaches to the treatment of Alzheimer’s Disease and Related Dementias (ADRD); 
• Identify the emerging and promising agents in the treatment and management of early Alzheimer’s disease (AD); 
• Recognize geriatric psychopharmacology and how to optimally treat the more challenging geriatric mental health conditions;
• Describe the promotion of brain health and longevity through evidence-based prevention.

ACCREDITATION

PHYSICIAN CREDIT: 

University of Miami Leonard M. Miller School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Miami Leonard M. Miller School of Medicine designates these live activities for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Through an agreement between the American Medical Association and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 Credit™ to an equivalent number of European CME Credits® (ECMECs®).

PSYCHOLOGIST CREDIT:

The University of Miami Leonard M. Miller School of Medicine is approved by the American Psychological Association (APA) to sponsor continuing education for psychologists. The University of Miami Leonard M. Miller School of Medicine maintains responsibility for this program and its content. 15.00 CE credits will be awarded to psychologists for attendance at these seminars.

NURSE PRACTITIONERS & REGISTERED NURSES CREDIT:

These activities have been submitted to ANA Massachusetts for approval to award contact hours. ANA Massachusetts is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

For more information please visit the official event page.